Might 6, 2024 – Teleflex Included introduced the presentation of a number of medical research on the 2024 American Urological Affiliation Annual Assembly, held Might 3-6, 2024 in San Antonio, Texas. These research add extra medical proof across the security, efficacy and affected person expertise with a prostatic urethral elevate (PUL) utilizing the UroLift^™ System for benign BPH.

Along with presenting medical information, Teleflex affords the primary alternative to view the UroLift™ 2 System with Superior Tissue Management (ATC), which was just lately accepted by the FDA. The UroLift™ 2 ATC System supplies physicians with better confidence, simpler management of obstructive tissue, and concentrating on accuracy by way of tissue management wings and laser-etched needle markers designed to make tissue manipulation and implant supply extra correct.

BPH is a standard situation wherein the prostate enlarges as males age. The enlarged prostate can press and block the urethra, inflicting disagreeable urinary tract signs.

Study extra